adplus-dvertising
Connect with us

Health

Will Canadians get to choose which COVID-19 vaccine they get? – Global News

Published

 on


Two vaccines are already approved, two are under review, and two more are in the pipeline, making it possible that Canadians could eventually have access to at least six different COVID-19 vaccines.

With so many options, will Canadians get to choose which shot they get?

Read more:
Coronavirus: What you need to know about mRNA vaccines

Federal minister of international development Karina Gould told a Global News station in London, Ont., that “the vaccine distribution happens via the provinces” and so “it would be up to the government of Ontario to decide where vaccines are going (in Ontario),” for example.

Global News has reached out to Canada’s provinces and territories for comment, with the majority suggesting it is too soon to say.

Story continues below advertisement

British Columbia’s ministry of health said those vaccinated in Phase 1 of its plan do not have a choice between Pfizer and Moderna (though they always know which one they’re receiving) but once more vaccines become available that could change, depending on supply and availability.

A spokesperson for Alberta said that “we are not providing eligible groups with a choice of vaccine at this time.”

Saskatchewan said only that “the availability of vaccine is determined by the supply as well as the logistic and handling requirements of the vaccine.”

A spokesperson for Manitoba said “it is far too early to speculate about vaccine choice” but that the province will “continue to update Manitobans with more information as it becomes available.”

Ontario did not provide a statement by publication time.

Read more:
Ontario updates COVID-19 vaccine plan as Pfizer delays continue

In Quebec, a spokesperson said, “due to the limited number of doses currently available to us, we cannot offer people a choice of vaccine,” adding, “it is the federal government that is responsible for the supply of the vaccine against COVID-19 to the provinces and territories.”

A spokesperson for New Brunswick said it’s “too early to say what will happen” when more vaccine options are made available.

Story continues below advertisement

In Nova Scotia, a spokesperson said only that “the Province makes decisions on which vaccine to send to a clinic based (on) factors such as location, supply, transportation and storage requirements.”

The Government of Newfoundland and Labrador’s department of health and community services told Global News that “the goal is to vaccinate as many people as possible as vaccines arrive in the province. At this time, Newfoundland and Labrador is not planning to provide vaccine options.”

In Prince Edward Island, a spokesperson said that “at this time, Islanders are not choosing between Moderna and Pfizer vaccines.”

Yukon said that since additional vaccines have yet to be approved “this is not a decision that has been considered yet.”

The Northwest Territories said “we will speak to that when another option (not Pfizer) is available.”

Nunavut said only that it is currently allocated the Moderna vaccine due to the extreme cold storage requirements of the Pfizer vaccine and resulting logistical challenges.






1:09
Trudeau insists Canada on track for vaccine goals amid opposition questions about supply delay


Trudeau insists Canada on track for vaccine goals amid opposition questions about supply delay

The ethics of choice

Beyond the question of whether or not Canadians will get to choose which company’s vaccine they get, however, is the question of whether Canadians should have that choice.

Story continues below advertisement

Bioethicist at Western University in London, Ont., Charles Weijer says at this point in time priority groups are the focus but it’s “conceivable” that Canadians could have that choice in the latter half of this year.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

“It’s actually a day to look forward to, I think. Once there is choice, we’ll know that there are adequate supplies and that’ll be a good thing.”

Read more:
In the fight against COVID-19, wealth plays a significant role

Weijer, who was also a member of the working group that developed the World Health Organization’s ethical guidelines for COVID-19 human challenge studies, suggests that the COVID-19 vaccine should be treated like other medical interventions in Canada.

“If there’s more than one product licensed and available, typically we allow Canadians to make a choice.”

Natalie Kofler, molecular biologist and lecturer at the Center for Biomedical Ethics at Harvard Medical School, agreed that it is a possibility but raised concerns about worldwide distribution of vaccines.

“Given that Canada seems to have so many vaccines available, there might be the choice at some point,” she said, referencing that Canada has secured enough doses to vaccinate the population many times over.

Story continues below advertisement

Kofler says if scientific data shows that certain vaccines are better for those who are pregnant or for youths, for example, then those groups should have access to those vaccines, but when it comes to widespread choice, it becomes “a dicey question.”

She stressed that the pandemic is a global crisis that requires a global response.

“Before we start vaccinating our entire population, are there people who really need them in other countries that need this first so that we can ensure that we move beyond this pandemic as a healthy global community? Because what’s really concerning is what this can set up as an even greater emergence of inequity within this world,” she said.

“Many countries are going to be left behind if they can’t get up and running by at least having their front-line workers and those really most vulnerable being vaccinated.”

An international crisis

“Ensuring equitable access globally to COVID-19 vaccines is an exceptionally important issue,” Weijer said.

“Part of the reason it matters is our history in this space is just so bad.”

Weijer pointed to the 2009 H1N1 influenza pandemic as a very recent example. In that case, he says, a vaccine was rapidly generated and then “rich countries just systematically outbid poorer countries for access to the vaccine.”

Story continues below advertisement

As part of the response to COVID-19, the WHO partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and global vaccine alliance Gavi to launch COVAX, an initiative in which Weijer says Canada has played “an important role.”

Read more:
Your guide to COVAX, the WHO’s coronavirus global vaccine plan

Minister Gould is co-chairing the COVAX Advance Market Commitment (AMC) Engagement Group “which is the mechanism to ensure that vaccines are delivered in the developing world,” she told Global News.

“From the get-go, Canada has been supporting multilateral and global efforts to make sure there is a fair and equitable distribution of vaccines,” she said.

“We can be at a point where we’ve vaccinated hopefully everyone here in Canada by September, but if the rest of the world still has the pandemic raging we’re not going to be able to get back to the things that we like to do — travelling, trading, visiting family and friends, having people come visit us here in Canada — until we really get the pandemic under control everywhere.”

Canada has contributed $220 million to the initiative, Gould says, and has also committed to donating excess physical vaccines to COVAX.

COVAX can also expect a boost from the United States, which confirmed intentions to participate just hours after Joe Biden officially took office as president of the United States last Wednesday, the Washington Post reported.

Story continues below advertisement


Click to play video 'Coronavirus: Vaccine nationalism puts world on brink of ‘catastrophic moral failure,’ says WHO chief'



2:45
Coronavirus: Vaccine nationalism puts world on brink of ‘catastrophic moral failure,’ says WHO chief


Coronavirus: Vaccine nationalism puts world on brink of ‘catastrophic moral failure,’ says WHO chief – Jan 18, 2021

Just two days earlier, WHO Director-General Tedros Adhanom Ghebreyesus had warned that the world is on the brink of “catastrophic moral failure” in sharing vaccines. At that time, at least 56 bilateral deals had been signed.

As of Jan. 18, Tedros said more than 39 million vaccine doses had been administered in 49 higher-income countries whereas just 25 doses had been given in one poor country.

“We’re not all in the same pot putting money in and also getting our doses through COVAX,” Kofler said.

“We’re putting money in, then we’re also doing your side game of buying doses — more doses than we actually even need — and making sure we’re fine. Things fall a little bit apart when you don’t have vested interest in the success of the project.”

Story continues below advertisement

She added that COVAX is also “delayed in their approval process,” having only recently approved the Pfizer-BioNTech vaccine.

“That’s also on the company’s responsibility because they’re choosing where they enter in for emergency approval in these different nations. And they’ve also chosen to first go for approval in high-income countries that are likely going to be more profitable for these companies once they send out their shipments.”

Who gets the most effective vaccines?

So far, Canada has approved the Pfizer and Moderna vaccines which are both said to be over 90 per cent effective in protecting people from the coronavirus.

The AstraZeneca and Oxford University vaccine and the Johnson & Johnson vaccine are currently under review in Canada, with a decision on AstraZeneca expected first.

A spokesperson for AstraZeneca told Global News on Jan. 21 that, so far, the United Kingdom, Argentina, Dominican Republic, El Salvador, India, Mexico, and Morocco “have provided authorization” for emergency supply of its vaccine.

A Public Health Agency of Canada spokesperson told Global News on Jan. 19 that Health Canada experts will be taking part in a meeting of the European Medicines Agency, EMA, on Jan. 29 “to discuss authorization of the AstraZeneca vaccine.”

Pooled data from December showed an efficacy rate of 70 per cent for the AstraZeneca vaccine.

Story continues below advertisement

Read more:
AstraZeneca says reports of 8% coronavirus vaccine efficacy in seniors are ‘incorrect’

Kofler says efficacy is a “challenging thing to really nail down at this point.”

“These weren’t challenge trials (which involve people being deliberately infected), it was people going about their daily life to see if they were somewhat more protected — they were still wearing masks, they were still doing other things to protect themselves from COVID,” she explained.

“They are statistically sound, I’m not debating that. I’m just saying that I think it’s likely that as time progresses, AstraZeneca’s efficacy will probably work out to be a bit higher than what it’s showing.

“Scientifically, there’s no reason to believe it wouldn’t be a highly effective vaccination.”

Weijer says the AstraZeneca vaccine, and a few others, were always going to be the most appropriate choices for low- and middle-income countries.

“If differential efficacy was driving the choices that Canada was making or was driving the choices that low- and middle-income countries were making, that certainly would be unfair. But I don’t think that’s what’s been going on.”

Read more:
Canada has approved 2 coronavirus vaccines. How are other candidates progressing?

Story continues below advertisement

Instead, Weijer says decision-making comes down to cost and refrigeration.

“Pfizer’s about $25 a dose. The Moderna’s about $40 a dose. That’s unaffordable for low-income countries. The AstraZeneca vaccine comes in at around $3 a dose.”

As well, because the AstraZeneca vaccine is an adenoviral vector vaccine, it only requires regular refrigeration instead of freezing like the Moderna vaccine or deep-freezing like the Pfizer vaccine, which are both mRNA vaccines.

“The lack of access to sort of basic refrigeration in the poorest countries in the world before coronavirus was interfering with the delivery of about 40 per cent of of the world’s vaccine doses,” he stressed.

“This is a longstanding problem. The AstraZeneca vaccine, therefore, was really the only one that was going to be feasible for low- and middle-income countries.”

— with files from Global News’ Jigar Patel, Sean Boynton, and Emerald Bensadoun as well as Reuters’ Emma Farge.

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Health

What’s the greatest holiday gift: lips, hair, skin? Give the gift of great skin this holiday season

Published

 on

Give the gift of great skin this holiday season

Skinstitut Holiday Gift Kits take the stress out of gifting

Toronto, October 31, 2024 – Beauty gifts are at the top of holiday wish lists this year, and Laser Clinics Canada, a leader in advanced beauty treatments and skincare, is taking the pressure out of seasonal shopping. Today, Laser Clincs Canada announces the arrival of its 2024 Holiday Gift Kits, courtesy of Skinstitut, the exclusive skincare line of Laser Clinics Group.

In time for the busy shopping season, the limited-edition Holiday Gifts Kits are available in Laser Clinics locations in the GTA and Ottawa. Clinics are conveniently located in popular shopping centers, including Hillcrest Mall, Square One, CF Sherway Gardens, Scarborough Town Centre, Rideau Centre, Union Station and CF Markville. These limited-edition Kits are available on a first come, first served basis.

“These kits combine our best-selling products, bundled to address the most relevant skin concerns we’re seeing among our clients,” says Christina Ho, Senior Brand & LAM Manager at Laser Clinics Canada. “With several price points available, the kits offer excellent value and suit a variety of gift-giving needs, from those new to cosmeceuticals to those looking to level up their skincare routine. What’s more, these kits are priced with a savings of up to 33 per cent so gift givers can save during the holiday season.

There are two kits to select from, each designed to address key skin concerns and each with a unique theme — Brightening Basics and Hydration Heroes.

Brightening Basics is a mix of everyday essentials for glowing skin for all skin types. The bundle comes in a sleek pink, reusable case and includes three full-sized products: 200ml gentle cleanser, 50ml Moisture Defence (normal skin) and 30ml1% Hyaluronic Complex Serum. The Brightening Basics kit is available at $129, a saving of 33 per cent.

Hydration Heroes is a mix of hydration essentials and active heroes that cater to a wide variety of clients. A perfect stocking stuffer, this bundle includes four deluxe products: Moisture 15 15 ml Defence for normal skin, 10 ml 1% Hyaluronic Complex Serum, 10 ml Retinol Serum and 50 ml Expert Squalane Cleansing Oil. The kit retails at $59.

In addition to the 2024 Holiday Gifts Kits, gift givers can easily add a Laser Clinic Canada gift card to the mix. Offering flexibility, recipients can choose from a wide range of treatments offered by Laser Clinics Canada, or they can expand their collection of exclusive Skinstitut products.

 

Brightening Basics 2024 Holiday Gift Kit by Skinstitut, available exclusively at Laser Clincs Canada clinics and online at skinstitut.ca.

Hydration Heroes 2024 Holiday Gift Kit by Skinstitut – available exclusively at Laser Clincs Canada clinics and online at skinstitut.ca.

Continue Reading

Health

Here is how to prepare your online accounts for when you die

Published

 on

 

LONDON (AP) — Most people have accumulated a pile of data — selfies, emails, videos and more — on their social media and digital accounts over their lifetimes. What happens to it when we die?

It’s wise to draft a will spelling out who inherits your physical assets after you’re gone, but don’t forget to take care of your digital estate too. Friends and family might treasure files and posts you’ve left behind, but they could get lost in digital purgatory after you pass away unless you take some simple steps.

Here’s how you can prepare your digital life for your survivors:

Apple

The iPhone maker lets you nominate a “ legacy contact ” who can access your Apple account’s data after you die. The company says it’s a secure way to give trusted people access to photos, files and messages. To set it up you’ll need an Apple device with a fairly recent operating system — iPhones and iPads need iOS or iPadOS 15.2 and MacBooks needs macOS Monterey 12.1.

For iPhones, go to settings, tap Sign-in & Security and then Legacy Contact. You can name one or more people, and they don’t need an Apple ID or device.

You’ll have to share an access key with your contact. It can be a digital version sent electronically, or you can print a copy or save it as a screenshot or PDF.

Take note that there are some types of files you won’t be able to pass on — including digital rights-protected music, movies and passwords stored in Apple’s password manager. Legacy contacts can only access a deceased user’s account for three years before Apple deletes the account.

Google

Google takes a different approach with its Inactive Account Manager, which allows you to share your data with someone if it notices that you’ve stopped using your account.

When setting it up, you need to decide how long Google should wait — from three to 18 months — before considering your account inactive. Once that time is up, Google can notify up to 10 people.

You can write a message informing them you’ve stopped using the account, and, optionally, include a link to download your data. You can choose what types of data they can access — including emails, photos, calendar entries and YouTube videos.

There’s also an option to automatically delete your account after three months of inactivity, so your contacts will have to download any data before that deadline.

Facebook and Instagram

Some social media platforms can preserve accounts for people who have died so that friends and family can honor their memories.

When users of Facebook or Instagram die, parent company Meta says it can memorialize the account if it gets a “valid request” from a friend or family member. Requests can be submitted through an online form.

The social media company strongly recommends Facebook users add a legacy contact to look after their memorial accounts. Legacy contacts can do things like respond to new friend requests and update pinned posts, but they can’t read private messages or remove or alter previous posts. You can only choose one person, who also has to have a Facebook account.

You can also ask Facebook or Instagram to delete a deceased user’s account if you’re a close family member or an executor. You’ll need to send in documents like a death certificate.

TikTok

The video-sharing platform says that if a user has died, people can submit a request to memorialize the account through the settings menu. Go to the Report a Problem section, then Account and profile, then Manage account, where you can report a deceased user.

Once an account has been memorialized, it will be labeled “Remembering.” No one will be able to log into the account, which prevents anyone from editing the profile or using the account to post new content or send messages.

X

It’s not possible to nominate a legacy contact on Elon Musk’s social media site. But family members or an authorized person can submit a request to deactivate a deceased user’s account.

Passwords

Besides the major online services, you’ll probably have dozens if not hundreds of other digital accounts that your survivors might need to access. You could just write all your login credentials down in a notebook and put it somewhere safe. But making a physical copy presents its own vulnerabilities. What if you lose track of it? What if someone finds it?

Instead, consider a password manager that has an emergency access feature. Password managers are digital vaults that you can use to store all your credentials. Some, like Keeper,Bitwarden and NordPass, allow users to nominate one or more trusted contacts who can access their keys in case of an emergency such as a death.

But there are a few catches: Those contacts also need to use the same password manager and you might have to pay for the service.

___

Is there a tech challenge you need help figuring out? Write to us at onetechtip@ap.org with your questions.

Source link

Continue Reading

Health

Pediatric group says doctors should regularly screen kids for reading difficulties

Published

 on

 

The Canadian Paediatric Society says doctors should regularly screen children for reading difficulties and dyslexia, calling low literacy a “serious public health concern” that can increase the risk of other problems including anxiety, low self-esteem and behavioural issues, with lifelong consequences.

New guidance issued Wednesday says family doctors, nurses, pediatricians and other medical professionals who care for school-aged kids are in a unique position to help struggling readers access educational and specialty supports, noting that identifying problems early couldhelp kids sooner — when it’s more effective — as well as reveal other possible learning or developmental issues.

The 10 recommendations include regular screening for kids aged four to seven, especially if they belong to groups at higher risk of low literacy, including newcomers to Canada, racialized Canadians and Indigenous Peoples. The society says this can be done in a two-to-three-minute office-based assessment.

Other tips encourage doctors to look for conditions often seen among poor readers such as attention-deficit hyperactivity disorder; to advocate for early literacy training for pediatric and family medicine residents; to liaise with schools on behalf of families seeking help; and to push provincial and territorial education ministries to integrate evidence-based phonics instruction into curriculums, starting in kindergarten.

Dr. Scott McLeod, one of the authors and chair of the society’s mental health and developmental disabilities committee, said a key goal is to catch kids who may be falling through the cracks and to better connect families to resources, including quicker targeted help from schools.

“Collaboration in this area is so key because we need to move away from the silos of: everything educational must exist within the educational portfolio,” McLeod said in an interview from Calgary, where he is a developmental pediatrician at Alberta Children’s Hospital.

“Reading, yes, it’s education, but it’s also health because we know that literacy impacts health. So I think that a statement like this opens the window to say: Yes, parents can come to their health-care provider to get advice, get recommendations, hopefully start a collaboration with school teachers.”

McLeod noted that pediatricians already look for signs of low literacy in young children by way of a commonly used tool known as the Rourke Baby Record, which offers a checklist of key topics, such as nutrition and developmental benchmarks, to cover in a well-child appointment.

But he said questions about reading could be “a standing item” in checkups and he hoped the society’s statement to medical professionals who care for children “enhances their confidence in being a strong advocate for the child” while spurring partnerships with others involved in a child’s life such as teachers and psychologists.

The guidance said pediatricians also play a key role in detecting and monitoring conditions that often coexist with difficulty reading such as attention-deficit hyperactivity disorder, but McLeod noted that getting such specific diagnoses typically involves a referral to a specialist, during which time a child continues to struggle.

He also acknowledged that some schools can be slow to act without a specific diagnosis from a specialist, and even then a child may end up on a wait list for school interventions.

“Evidence-based reading instruction shouldn’t have to wait for some of that access to specialized assessments to occur,” he said.

“My hope is that (by) having an existing statement or document written by the Canadian Paediatric Society … we’re able to skip a few steps or have some of the early interventions present,” he said.

McLeod added that obtaining specific assessments from medical specialists is “definitely beneficial and advantageous” to know where a child is at, “but having that sort of clear, thorough assessment shouldn’t be a barrier to intervention starting.”

McLeod said the society was partly spurred to act by 2022’s “Right to Read Inquiry Report” from the Ontario Human Rights Commission, which made 157 recommendations to address inequities related to reading instruction in that province.

He called the new guidelines “a big reminder” to pediatric providers, family doctors, school teachers and psychologists of the importance of literacy.

“Early identification of reading difficulty can truly change the trajectory of a child’s life.”

This report by The Canadian Press was first published Oct. 23, 2024.

Source link

Continue Reading

Trending